(Q37788220)

23 August 2017

title

Berberine: a potential phytochemical with multispectrum therapeutic activities (English)

1 reference

23 August 2017

1 reference

Parameswara Rao Vuddanda

series ordinal

1

1 reference

23 August 2017

Subhashis Chakraborty

series ordinal

2

1 reference

23 August 2017

Sanjay Singh

series ordinal

3

1 reference

23 August 2017

language of work or name

English

0 references

publication date

1 October 2010

1 reference

Expert Opinion on Investigational Drugs

23 August 2017

published in

1 reference

23 August 2017

volume

19

1 reference

23 August 2017

issue

10

1 reference

23 August 2017

page(s)

1297-1307

1 reference

Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Antimicrobial activity of berberine--a constituent of Mahonia aquifolium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Leishmania donovani: amastigote inhibition and mode of action of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Influence of berberine sulfate on synthesis and expression of Pap fimbrial adhesin in uropathogenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Protective effect of berberine on beta cells in streptozotocin- and high-carbohydrate/high-fat diet-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Efficacy of berberine in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

On the mechanism of antidepressant-like action of berberine chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine-induced LDLR up-regulation involves JNK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Mechanism of the aortic relaxation induced by low concentrations of berberine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Mechanism of vasodilatory effect of berberine in rat mesenteric artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

The anti-inflammatory potential of berberine in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Transporters and drug discovery: why, when, and how.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Intestinal drug transporters: in vivo function and clinical importance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Role of transport proteins in drug absorption, distribution and excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Scientific perspectives on drug transporters and their role in drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

The P-glycoprotein multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

The power of the pump: mechanisms of action of P-glycoprotein (ABCB1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Recent progress in understanding the mechanism of P-glycoprotein-mediated drug efflux.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Functional role of P-glycoprotein in limiting peroral drug absorption: optimizing drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Importance of P-glycoprotein at blood-tissue barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

The involvement of P-glycoprotein in berberine absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Modulation of intestinal P-glycoprotein function by polyethylene glycols and their derivatives by in vitro transport and in situ absorption studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Polymeric particulates to improve oral bioavailability of peptide drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Lipid--an emerging platform for oral delivery of drugs with poor bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

Novel double coated nanocapsules for intestinal delivery and enhanced oral bioavailability of tacrolimus, a P-gp substrate drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.2010.517745

10.1517/13543784.2010.517745

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference